IL-1β, IL-6, and CRP are considered to be closely involved in the progression of hypertension.27,361–363 However, a large clinical study have shown that the use of IL-1β antibody did not reduce the incidence of hypertension.364 Thus, the use of anti-inflammatory therapy to lower BP requires more in-depth study. Here, CRP is linked to hypertensive disorder.